Abstract
There is a pressing need to improve the understanding of safety issues during drug development and post-approval. Our interviewees this month explain their roles in efforts to enhance drug safety.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Rights and permissions
About this article
Cite this article
Drug safety. Nat Rev Drug Discov 6, 937 (2007). https://doi.org/10.1038/nrd2461
Issue date:
DOI: https://doi.org/10.1038/nrd2461
This article is cited by
-
Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews
Journal of General Internal Medicine (2019)
